Skip to main content
search

Market Access & Commercial

Sign up

Latest resources

Featured resource

Everything you need to know about ILAP 2.0
Everything you need to know about ILAP 2.0White Paper

Everything you need to know about ILAP 2.0

This white paper share’s key insights on the relaunch of MHRA’s Innovative Licensing and Access Pathway (ILAP).

Market access & commercial resources

Patient Services Strategy Fact Sheet
Patient Services Strategy Fact SheetFact Sheet

Patient Services Strategy Fact Sheet

Certara’s Patient Services Strategy offering is flexible based on your budget and project type, and focused on helping biopharma companies design impactful programs that…
Using cost-effectiveness models for smarter drug development and healthcare decisions
Using cost-effectiveness models for smarter drug development and healthcare decisionsBlog

Using cost-effectiveness models for smarter drug development and healthcare decisions

April 14, 2025 Editor’s note: This is the second in a series of four articles on the crucial role health…
Tackling Affordability with Direct-to-Patient Sales
Tackling Affordability with Direct-to-Patient SalesBlog

Tackling Affordability with Direct-to-Patient Sales

April 11, 2025 Accessing affordable healthcare is one of the biggest challenges U.S. patients face. Historically, the pharmaceutical industry has…
Certainty US 2025
Certainty US 2025Live Events

Certainty US 2025

May 7-8, 2025 | Philadelphia, PA

Latest market access & commercialization blogs

Meet our experts at the following events

All Market Access & Commercial resources

Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.